© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Science News

Group of Friends Gays Celebrating and Dancing
Black and Latino Folks Are Less Likely to Be Referred for PrEP
hiv virus
Understanding Where HIV Hides Offers Clues for a Cure
DNA Pills molecules lab illustration science research
2021 Top HIV Science Stories

Gay Men With HIV Should Be Informed They Can Have Children

Informing gay and bi men that parenthood is possible through U=U could quell HIV stigma.

Starting Hepatitis C Treatment at Time of Diagnosis Leads to High Cure Rate

Pairing HCV testing and treatment eliminates the need to navigate the medical system.

FDA Approves New Triple-Target Hepatitis B Vaccine

The PreHevbrio vaccine produces higher antibody levels and offers faster protection.

HIV Treatment Means Fewer Orphans Too

A study showed that as HIV treatment expanded, teens lost fewer parents to the virus.

COVID-19 Vaccination Associated With Small, Temporary Increase in Menstrual Cycle Length

On average, the first vaccination dose was associated with a 0.71-day increase in cycle length and the second dose with a 0.91-day increase.

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption
a US dollar symbol in a life preserver
Some People With HIV Don’t Adhere to Treatment to Save Money
There’s Never Been a Better Time to Get Pregnant If One of You Has HIV
POZ March 2019 cover U=U Undetectable = Untransmitable
Communicating Undetectable Equals Untransmittable
The Science Is Clear: With HIV, Undetectable Equals Untransmittable
4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Dominican Republic Is Doing the Most to Fund Ending HIV Among Trans People

The nation tops the list of countries that not only include trans people in their plans to end HIV but also back policy with funding.

Tivicay Bests Non-Integrase Therapy as First- and Second-Line HIV Treatment For Kids

A high-quality trial should improve access to dolutegravir for children worldwide.

Eating Healthier and Moving More Make Older People With HIV Feel Better

Maybe it’s time to make your New Year’s resolution.

NIH Scientists Urge Pursuit of Universal Coronavirus Vaccine

SARS-CoV-2 will probably continue to circulate indefinitely, and animal coronaviruses may emerge at any time.
Molnupiravir capsules (Merck)

FDA OKs Second COVID Antiviral Pill for Limited Use

Molnupiravir is authorized for people at high risk for severe COVID-19 when other treatment options are not available.

Hot topics

#Cure
#Long-Term Survivors
Ounce of Prevention sign against a blue sky
#Prevention
PrEP written on a chalkboard
#PrEP

High CD4 Counts Equal Longevity, Except for Heart Disease

A large analysis of Austrian people living with HIV suggests that high CD4 counts are no protection against heart disease.
Paxlovid pills in production

FDA Authorizes First Antiviral Pill for COVID-19

Paxlovid, which reduces the risk of hospitalization or death by about 90%, is expected to be a game-changer.

Long-Acting HIV Therapy Hits a Snag

Studies of islatravir are put on hold after participants experience declining CD4 and lymphocyte counts.

Apretude Approved—the First Long-Acting Injectable PrEP Option

Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.
Advertisement
Features
Newsfeed

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ